Pilot study of exposure and response prevention for Japanese patients with obsessive-compulsive disorder

被引:3
作者
Shinmei, Issei [1 ]
Kanie, Ayako [1 ]
Kobayashi, Yuki [1 ]
Nakayama, Noriko [1 ]
Takagishi, Yuriko [1 ]
Iijima, Sonoko [1 ]
Takebayashi, Yoshitake [1 ,2 ]
Horikoshi, Masaru [1 ]
机构
[1] Natl Ctr Neurol & Psychiat, Natl Ctr Cognit Behav Therapy & Res, 4-1-1 Ogawa Higashi, Kodaira, Tokyo 1878553, Japan
[2] Fukushima Med Univ, Radiat Med Sci Ctr, 1 Hikarigaoka, Fukushima 9601295, Japan
关键词
Obsessive-compulsive disorder; Exposure and response prevention; Cognitive-behavioral therapy; Family; Japanese; COGNITIVE-BEHAVIORAL THERAPY; CLINICAL-TESTS; VALIDATION; INVENTORY; VALIDITY; SCALE; SF-36;
D O I
10.1016/j.jocrd.2017.08.002
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
This pilot study was conducted to evaluate the feasibility and efficacy of exposure and response prevention therapy in Japanese patients with obsessive-compulsive disorder. This study was the first to examine the effectiveness of exposure and response prevention therapy provided by Japanese clinical psychologists. The sample comprised 37 adults (male = 17, female = 20, mean age = 35.7 years, standard deviation [SD] = 10, mean Yale-Brown Obsessive Compulsive Scale score = 26.9, SD = 23.35) with a diagnosis of obsessive-compulsive disorder receiving treatment. Individually administrated exposure and response prevention was provided to the 37 patients with obsessive-compulsive disorder. We evaluated the feasibility and safety of the program using the dropout rate and adverse events. The primary outcome was the reduction of the Yale-Brown Obsessive Compulsive Scale score between the pre- and post-treatment periods. Secondary outcomes were depression, anxiety, and quality of life. Of the 37 patients, 5(14%) dropped out and 32(86%) completed the entire program. No severe adverse event was observed. The patients reported significant reductions in the Yale-Brown Obsessive Compulsive Scale score (obsession: Hedges' g = 2.11, 95% Cl [1.57, 2.68]; compulsion: Hedges' g = 2.05, 95% CI [1.41, 2.56]). Some secondary outcomes (depression and quality of life) also showed significant change. The results suggest that the exposure and response prevention program provided by Japanese clinical psychologists is an efficacious and feasible treatment approach for Japanese patients with obsessive-compulsive disorder.
引用
收藏
页码:19 / 26
页数:8
相关论文
共 33 条
[1]  
American Psychiatric Association A. Association A.P, 2013, Diagnostic and Statistical Manual of Mental Disorders, DOI [DOI 10.1176/APPI.BOOKS.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596.744053]
[2]  
Beck A, 2009, Manual for the BDI-II
[3]   AN INVENTORY FOR MEASURING DEPRESSION [J].
BECK, AT ;
ERBAUGH, J ;
WARD, CH ;
MOCK, J ;
MENDELSOHN, M .
ARCHIVES OF GENERAL PSYCHIATRY, 1961, 4 (06) :561-&
[4]  
CALVOCORESSI L, 1995, AM J PSYCHIAT, V152, P441
[5]   Validation of a brief measure of anxiety-related severity and impairment: The Overall Anxiety Severity and Impairment Scale (OASIS) [J].
Campbell-Sills, Laura ;
Norman, Sonya B. ;
Craske, Michelle G. ;
Sullivan, Greer ;
Lang, Ariel J. ;
Chavira, Denise A. ;
Bystritsky, Alexander ;
Sherbourne, Cathy ;
Roy-Byrne, Peter ;
Stein, Murray B. .
JOURNAL OF AFFECTIVE DISORDERS, 2009, 112 (1-3) :92-101
[6]  
First M.B., 2002, STRUCTURED CLIN INTE
[7]   Context in the clinic: How well do cognitive-behavioral therapies and medications work in combination? [J].
Foa, EB ;
Franklin, ME ;
Moser, J .
BIOLOGICAL PSYCHIATRY, 2002, 52 (10) :987-997
[8]  
Foa Edna B, 2010, Dialogues Clin Neurosci, V12, P199
[9]   The descriptive epidemiology of obsessive-compulsive disorder [J].
Fontenelle, LF ;
Mendlowicz, MV ;
Versiani, M .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2006, 30 (03) :327-337
[10]   Psychometric and clinical tests of validity of the Japanese SF-36 Health Survey [J].
Fukuhara, S ;
Ware, JE ;
Kosinski, M ;
Wada, S ;
Gandek, B .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1998, 51 (11) :1045-1053